Population-based prevalence of hepatitis B and C virus, HIV, syphilis, gonorrhoea and chlamydia in male injection drug users in Lagos, Nigeria

Int J STD AIDS. 2013 Aug;24(8):619-25. doi: 10.1177/0956462413477553. Epub 2013 Jul 19.

Abstract

There is little research on injecting drug use in Nigeria. We investigated the prevalence of HIV, hepatitis B and C, and sexually transmitted infections (STIs) among male injection drug users (IDUs) in Lagos. Male IDUs (N = 328) were recruited through respondent-driven sampling. Participants completed an interview about their sexual and injecting risk behaviours and were tested for hepatitis B surface antigen (HBV), hepatitis C antibody (HCV), HIV and syphilis, as well as genital chlamydia and gonorrhoea infections. Three-quarters of IDUs (74%) reported injecting drugs in the past one month although most did not share needles (92%) and the majority obtained sterile needles from pharmacists (87%). Estimated HBV, HCV, HIV, syphilis, gonorrhoea and chlamydia prevalences were 7.8%, 7.7%, 0.9%, 1.9%, 0.0%, and 3.7%, respectively. The burden of HIV is presently low among IDUs in Lagos. Changes in accessibility to sterile needles at pharmacists would likely have a deleterious effect on IDUs' health. HBV vaccination and HCV prevention programmes for IDUs are urgently needed.

Keywords: AIDS; HIV; Nigeria; chlamydia; epidemiology; gonorrhoea; hepatitis B; hepatitis C; injecting drug users; injection drug users; prevalance; sexually transmitted infection; syphilis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Chlamydia
  • Chlamydia Infections / epidemiology*
  • Cross-Sectional Studies
  • Drug Users / statistics & numerical data*
  • Gonorrhea / epidemiology*
  • HIV Infections / epidemiology*
  • Hepatitis B / epidemiology*
  • Hepatitis B Surface Antigens / analysis
  • Hepatitis C / epidemiology*
  • Hepatitis C Antibodies / analysis
  • Humans
  • Male
  • Middle Aged
  • Nigeria / epidemiology
  • Population Surveillance
  • Prevalence
  • Risk Factors
  • Sexual Behavior
  • Socioeconomic Factors
  • Substance Abuse, Intravenous / epidemiology*
  • Syphilis / epidemiology*
  • Young Adult

Substances

  • Hepatitis B Surface Antigens
  • Hepatitis C Antibodies